All Blogs

Jan 21, 2019

Ladies, January is the month of raising awareness about cervical cancer. In the US, 250000 women are affected every year. One can refrain from the cancer by avoiding human papillomavirus, or HPV, which is sexually transmitted. We can eliminate cervical cancer as a public health problem through intensified vaccinati...

Jan 18, 2019

Doctors now have a new weapon in the fight against cancer: detailed maps of the cells in a tumour that can be explored and analyzed in a virtual reality simulation that its creators say provides researchers with an intuitive new way to examine complex medical data that could lead to unexpected breakthroughs. Bui...

Jan 17, 2019

Anti-aging startup Juvenescence raises USD 46 Million Juvenescence has bagged the USD 46 million in series B financing. The investment tees the anti-ageing startup to progress the multi-asset pipeline. Jim Mellon, a British billionaire biotech investor, created Juvenescence with early Medivation backer Greg Bai...

Jan 16, 2019

A survey was done in which thousands of advanced cancers indicated a way to detect those that respond to revolutionary therapies that unleash an immune response against tumours. However, the results show difficulty level to translate an approach into a reliable clinical test. The findings are the latest evidence to...

Jan 15, 2019

Abbott’s pea-sized implant for congenital heart defects gets FDA approval FDA approved Abbott for its Amplatzer Piccolo Occluder, the implant designed for premature babies. The device is used to treat patent ductus arteriosus (PDA), a life-threatening opening in the hearts of premature newborns and is a minimal...

Jan 11, 2019

Breast cancer develops when breast tissue cells grow abnormally and multiply. In essence, the hormones-- estrogen and progesterone-- and excess levels of human epidermal growth factor receptor 2 (HER2) protein are the known drivers of breast cancer. By testing samples of breast cancer tissue for hormone receptors a...

Jan 10, 2019

Apollomics raises USD 100 Million for funding of transpacific cancer R&D plan Apollomics has raised USD 100 million for funding an oncology clinical trial program. The series B round sets Apollomics to progress its c-Met inhibitor and pipeline of other clinical-phase assets. OrbiMed Asia-backed Apo...

Jan 09, 2019

A range of rare genetic disorders is pinpointed by a deep-learning algorithm. This helps doctors and researchers by analysing pictures of people’s faces. Researchers describe the technology after the diagnostic aid, a smartphone app called Face2Gene. It relies on machine-learning algorithmsand brain-like neural...

Jan 08, 2019

The oral depression drug of Sage Therapeutics meets phase 3 efficacy A phase 3 trial of oral treatment of Sage Therapeutics for postpartum depression (PPD) has hit its primary endpoint. The drug, SAGE-217, showed significant improvements on a depression score and saw no fainting cases. SAGE-217 is an a...

Jan 04, 2019

In what could be regarded as a first of its kind, researchers from the Centre for Vision, Speech and Signal Processing at the University of Surrey in the United Kingdom have recently reported that they created two machine learning models that are able to precisely predict the severity of three common symptoms ...